Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015
(MP) is one of the most common etiological agents of community-acquired pneumonia (CAP) in children. We aimed to describe the clinical and epidemiological characteristics, treatment and outcome of children diagnosed with community-acquired MP pneumonia (CAMP) in a tertiary hospital in Valencia, Spai...
Gespeichert in:
| Veröffentlicht in: | Anales de Pediatría 2019-07, Vol.91 (1), p.21-29 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng ; spa |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 29 |
|---|---|
| container_issue | 1 |
| container_start_page | 21 |
| container_title | Anales de Pediatría |
| container_volume | 91 |
| creator | Aguilera-Alonso, David López Ruiz, Rocío Centeno Rubiano, Jose Morell García, Marta Valero García, Isabel Ocete Mochón, María Dolores Montesinos Sanchis, Elena |
| description | (MP) is one of the most common etiological agents of community-acquired pneumonia (CAP) in children. We aimed to describe the clinical and epidemiological characteristics, treatment and outcome of children diagnosed with community-acquired MP pneumonia (CAMP) in a tertiary hospital in Valencia, Spain.
Medical records of children |
| doi_str_mv | 10.1016/j.anpedi.2018.07.016 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179477316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2179477316</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-572ddece9b177f544543d8f71cdb6ace5d1ae14c153297930da8f3b608f3cfcb3</originalsourceid><addsrcrecordid>eNo1UEtLw0AYXASxpfYfiOzRg4n7SLLJUUp9QMWDeg5fdjd2y76aTQ49-s8NWC8zzDAMwyB0Q0lOCa0eDjn4qJXJGaF1TkQ-mxdoyXhBM1aLZoHWKR0IIYxTXhbVFVpwxuqGFNUS_WyjUdqZYMO3kWAxeIWlNf4swJ6SSTj0WAbnJm_GUwbyOJlBK_x2kiFaSA5w9HpywRvAxmO5N1YN2uN-CA4D_ojgTdrjGOJkYTTB3-N5LMlmKK_RZQ826fWZV-jrafu5ecl278-vm8ddFimrxqwUTCktddNRIfqyKMqCq7oXVKquAqlLRUHTQtKSs0Y0nCioe95VZEbZy46v0N1fbxzCcdJpbJ1JUlsLXocptYyKphCC02qO3p6jU-e0auNgHAyn9v82_gvFN3F1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179477316</pqid></control><display><type>article</type><title>Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Directory of Open Access Journals</source><source>Alma/SFX Local Collection</source><creator>Aguilera-Alonso, David ; López Ruiz, Rocío ; Centeno Rubiano, Jose ; Morell García, Marta ; Valero García, Isabel ; Ocete Mochón, María Dolores ; Montesinos Sanchis, Elena</creator><creatorcontrib>Aguilera-Alonso, David ; López Ruiz, Rocío ; Centeno Rubiano, Jose ; Morell García, Marta ; Valero García, Isabel ; Ocete Mochón, María Dolores ; Montesinos Sanchis, Elena</creatorcontrib><description>(MP) is one of the most common etiological agents of community-acquired pneumonia (CAP) in children. We aimed to describe the clinical and epidemiological characteristics, treatment and outcome of children diagnosed with community-acquired MP pneumonia (CAMP) in a tertiary hospital in Valencia, Spain.
Medical records of children <14 years with CAMP were retrospectively reviewed from January 2010 to December 2015. Patients with radiological evidence of pneumonia and microbiological confirmation of MP (PCR from nasopharyngeal swab and/or serum specific IgM) were considered CAMP.
One hundred and sixty two children were diagnosed with CAMP; median age 6 years (IQR: 4-9). The positive MP test rate among children with CAP progressively increased with age as did the empirical use of macrolides. There were two peaks of cases in 2011 and in 2015, being July, August, November and December the seasons with the higher number of cases. The most frequent radiological pattern was segmental infiltrate (62.3%) and 22 (13.6%) children had pleural effusion. It was noteworthy the mild symptomatology and low levels of inflammatory parameters that children with CAMP had. A macrolide was empirically initiated in 68.5% of cases. Hospital admission rate was inversely proportional to patient's age.
According to this study, older, less symptomatic patients and with lower inflammatory parameters had the greatest rate of MP infection among children with CAP and thus they could benefit of empiric macrolide therapy. Therefore, knowing the epidemiology of a geographical area may be important for the management of CAP in children.</description><identifier>EISSN: 2341-2879</identifier><identifier>DOI: 10.1016/j.anpedi.2018.07.016</identifier><identifier>PMID: 32289046</identifier><language>eng ; spa</language><publisher>Spain</publisher><ispartof>Anales de Pediatría, 2019-07, Vol.91 (1), p.21-29</ispartof><rights>2019 Asociación Española de Pediatría. Published by Elsevier España, S.L.U.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32289046$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aguilera-Alonso, David</creatorcontrib><creatorcontrib>López Ruiz, Rocío</creatorcontrib><creatorcontrib>Centeno Rubiano, Jose</creatorcontrib><creatorcontrib>Morell García, Marta</creatorcontrib><creatorcontrib>Valero García, Isabel</creatorcontrib><creatorcontrib>Ocete Mochón, María Dolores</creatorcontrib><creatorcontrib>Montesinos Sanchis, Elena</creatorcontrib><title>Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015</title><title>Anales de Pediatría</title><addtitle>An Pediatr (Engl Ed)</addtitle><description>(MP) is one of the most common etiological agents of community-acquired pneumonia (CAP) in children. We aimed to describe the clinical and epidemiological characteristics, treatment and outcome of children diagnosed with community-acquired MP pneumonia (CAMP) in a tertiary hospital in Valencia, Spain.
Medical records of children <14 years with CAMP were retrospectively reviewed from January 2010 to December 2015. Patients with radiological evidence of pneumonia and microbiological confirmation of MP (PCR from nasopharyngeal swab and/or serum specific IgM) were considered CAMP.
One hundred and sixty two children were diagnosed with CAMP; median age 6 years (IQR: 4-9). The positive MP test rate among children with CAP progressively increased with age as did the empirical use of macrolides. There were two peaks of cases in 2011 and in 2015, being July, August, November and December the seasons with the higher number of cases. The most frequent radiological pattern was segmental infiltrate (62.3%) and 22 (13.6%) children had pleural effusion. It was noteworthy the mild symptomatology and low levels of inflammatory parameters that children with CAMP had. A macrolide was empirically initiated in 68.5% of cases. Hospital admission rate was inversely proportional to patient's age.
According to this study, older, less symptomatic patients and with lower inflammatory parameters had the greatest rate of MP infection among children with CAP and thus they could benefit of empiric macrolide therapy. Therefore, knowing the epidemiology of a geographical area may be important for the management of CAP in children.</description><issn>2341-2879</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo1UEtLw0AYXASxpfYfiOzRg4n7SLLJUUp9QMWDeg5fdjd2y76aTQ49-s8NWC8zzDAMwyB0Q0lOCa0eDjn4qJXJGaF1TkQ-mxdoyXhBM1aLZoHWKR0IIYxTXhbVFVpwxuqGFNUS_WyjUdqZYMO3kWAxeIWlNf4swJ6SSTj0WAbnJm_GUwbyOJlBK_x2kiFaSA5w9HpywRvAxmO5N1YN2uN-CA4D_ojgTdrjGOJkYTTB3-N5LMlmKK_RZQ826fWZV-jrafu5ecl278-vm8ddFimrxqwUTCktddNRIfqyKMqCq7oXVKquAqlLRUHTQtKSs0Y0nCioe95VZEbZy46v0N1fbxzCcdJpbJ1JUlsLXocptYyKphCC02qO3p6jU-e0auNgHAyn9v82_gvFN3F1</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Aguilera-Alonso, David</creator><creator>López Ruiz, Rocío</creator><creator>Centeno Rubiano, Jose</creator><creator>Morell García, Marta</creator><creator>Valero García, Isabel</creator><creator>Ocete Mochón, María Dolores</creator><creator>Montesinos Sanchis, Elena</creator><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201907</creationdate><title>Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015</title><author>Aguilera-Alonso, David ; López Ruiz, Rocío ; Centeno Rubiano, Jose ; Morell García, Marta ; Valero García, Isabel ; Ocete Mochón, María Dolores ; Montesinos Sanchis, Elena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-572ddece9b177f544543d8f71cdb6ace5d1ae14c153297930da8f3b608f3cfcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aguilera-Alonso, David</creatorcontrib><creatorcontrib>López Ruiz, Rocío</creatorcontrib><creatorcontrib>Centeno Rubiano, Jose</creatorcontrib><creatorcontrib>Morell García, Marta</creatorcontrib><creatorcontrib>Valero García, Isabel</creatorcontrib><creatorcontrib>Ocete Mochón, María Dolores</creatorcontrib><creatorcontrib>Montesinos Sanchis, Elena</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Anales de Pediatría</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aguilera-Alonso, David</au><au>López Ruiz, Rocío</au><au>Centeno Rubiano, Jose</au><au>Morell García, Marta</au><au>Valero García, Isabel</au><au>Ocete Mochón, María Dolores</au><au>Montesinos Sanchis, Elena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015</atitle><jtitle>Anales de Pediatría</jtitle><addtitle>An Pediatr (Engl Ed)</addtitle><date>2019-07</date><risdate>2019</risdate><volume>91</volume><issue>1</issue><spage>21</spage><epage>29</epage><pages>21-29</pages><eissn>2341-2879</eissn><abstract>(MP) is one of the most common etiological agents of community-acquired pneumonia (CAP) in children. We aimed to describe the clinical and epidemiological characteristics, treatment and outcome of children diagnosed with community-acquired MP pneumonia (CAMP) in a tertiary hospital in Valencia, Spain.
Medical records of children <14 years with CAMP were retrospectively reviewed from January 2010 to December 2015. Patients with radiological evidence of pneumonia and microbiological confirmation of MP (PCR from nasopharyngeal swab and/or serum specific IgM) were considered CAMP.
One hundred and sixty two children were diagnosed with CAMP; median age 6 years (IQR: 4-9). The positive MP test rate among children with CAP progressively increased with age as did the empirical use of macrolides. There were two peaks of cases in 2011 and in 2015, being July, August, November and December the seasons with the higher number of cases. The most frequent radiological pattern was segmental infiltrate (62.3%) and 22 (13.6%) children had pleural effusion. It was noteworthy the mild symptomatology and low levels of inflammatory parameters that children with CAMP had. A macrolide was empirically initiated in 68.5% of cases. Hospital admission rate was inversely proportional to patient's age.
According to this study, older, less symptomatic patients and with lower inflammatory parameters had the greatest rate of MP infection among children with CAP and thus they could benefit of empiric macrolide therapy. Therefore, knowing the epidemiology of a geographical area may be important for the management of CAP in children.</abstract><cop>Spain</cop><pmid>32289046</pmid><doi>10.1016/j.anpedi.2018.07.016</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 2341-2879 |
| ispartof | Anales de Pediatría, 2019-07, Vol.91 (1), p.21-29 |
| issn | 2341-2879 |
| language | eng ; spa |
| recordid | cdi_proquest_miscellaneous_2179477316 |
| source | EZB-FREE-00999 freely available EZB journals; Directory of Open Access Journals; Alma/SFX Local Collection |
| title | Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A55%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidemiological%20and%20clinical%20analysis%20of%20community-acquired%20Mycoplasma%20pneumonia%20in%20children%20from%20a%20Spanish%20population,%202010-2015&rft.jtitle=Anales%20de%20Pediatr%C3%ADa&rft.au=Aguilera-Alonso,%20David&rft.date=2019-07&rft.volume=91&rft.issue=1&rft.spage=21&rft.epage=29&rft.pages=21-29&rft.eissn=2341-2879&rft_id=info:doi/10.1016/j.anpedi.2018.07.016&rft_dat=%3Cproquest_pubme%3E2179477316%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2179477316&rft_id=info:pmid/32289046&rfr_iscdi=true |